M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124/STAT3 pathway after ischemic

Zongwei Li1, Yaying Song2, Tingting He3

  • 1Shanghai Jiao Tong Affiliated Sixth People's Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.

Theranostics
|January 4, 2021
PubMed

Insights

Microglia-derived extracellular vesicles carrying miR-124 reduce glial scar formation and promote stroke recovery. This novel therapeutic approach targets astrocyte proliferation and aids neuronal regeneration after ischemic stroke.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Biology

Background:

  • Glial scars impede neuronal regeneration post-stroke.
  • Microglia-astrocyte interactions are implicated in glial scar formation, but microglia's precise role is unclear.

Purpose of the Study:

  • To investigate how microglia influence glial scar formation after stroke.
  • To explore the therapeutic potential of M2 microglial small extracellular vesicles for stroke recovery.

Main Methods:

  • Mice received M2 microglial small extracellular vesicles intravenously post-stroke.
  • Evaluated glial scar size, infarct volume, and neurological scores.
  • Analyzed microRNA and protein expression in peri-infarct brain tissue.

Main Results:

  • M2 microglial small extracellular vesicles reduced glial scars and improved stroke outcomes.
  • These vesicles, enriched in miR-124, inhibited astrocyte proliferation by targeting STAT3.
  • Astrocytes showed signs of neuronal progenitor cell transformation.

Conclusions:

  • Microglia regulate glial scar formation via small extracellular vesicles.
  • M2 microglial small extracellular vesicles represent a promising therapeutic strategy for stroke.
  • miR-124 is a key mediator in the therapeutic effects of these vesicles.

Related Concept Videos